Cleveland Clinic Breast Cancer Vaccine Trial Completed
Researchers have finished a phase one clinical trial for a vaccine designed to prevent aggressive breast cancer.
Updated on Oct. 14, 2026 in Cancer
Live Poll
Do you believe medical research should prioritize developing preventative vaccines for cancer?
A phase one clinical trial for a new breast cancer vaccine was completed at the Cleveland Clinic Hospital. The study involved 35 women and aimed to evaluate the potential for a preventative immunization against aggressive cancer.
Why it matters
The vaccine is designed to function similarly to traditional immunizations for infectious diseases by training the immune system to target cancer cells. This approach aims to provide a preventative option for women against aggressive forms of the disease.
The phase one study included 35 women. Three-quarters of the participants demonstrated a strong immune response to the vaccine, while the remaining quarter exhibited a modest immune response.
The players
Cleveland Clinic Hospital
This is a prominent academic medical center that served as the location for the phase one clinical trial.
U.S. Department of Defense
This federal executive department provided the necessary funding for the breast cancer vaccine study.
The details
The vaccine works by training the patient's immune system to identify and attack breast cancer cells. The project was funded by the U.S. Department of Defense and follows a standard three-phase development process.
Timeline
October 14, 2026: Article reporting the completed phase one trial.
Health Landscape
This trial represents the completion of the initial stage within the established three-phase development process. It follows a shift in medical research toward preventative immunizations for chronic conditions like cancer.
This development indicates a potential future option for preventative care against aggressive breast cancer. Patients should note that the vaccine is currently in the testing phases and is not yet available for clinical use.
The takeaway
The successful completion of this phase one trial marks a notable step toward a vaccine that could one day prevent cancer. Researchers are now looking toward future phases to confirm the vaccine's ability to protect the general female population.
Further reading
Learn more about ongoing research in Cancer.
Source note: This article includes information reported by KATV.
Live Poll
Do you believe medical research should prioritize developing preventative vaccines for cancer?
